US EditionFDA expands use of meningococcal vaccine for children – RamaOnHealthcare
Summary by ramaonhealthcare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
FDA expands use of meningococcal vaccine for children – RamaOnHealthcare
The FDA has approved expanded use of Sanofi Pasteur’s Menactra, a meningococcal conjugate vaccine for children aged 2 to 10. Menactra is now the first quadrivalent conjugate vaccine licensed in the U.S. to prevent meningococcal disease in this age group, according to a news release from Sanofi.Originally approved in 2005 for individuals aged 11 to [...]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
